Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05712447 · ClinicalTrials.gov registry record

Duchenne Muscular Dystrophy Video Assessment Registry

A clinical trial of Duchenne Muscular Dystrophy, sponsored by The Emmes Company.

Completed
Registry status
150
Enrollment target
1
Study location

NCT05712447 is a study of Duchenne Muscular Dystrophy that has completed, run by The Emmes Company. The registered enrollment target is 150 participants, below the 409-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05712447, a study of Duchenne Muscular Dystrophy, has completed, sponsored by The Emmes Company.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

ARISE is a prospective and longitudinal clinical study of individuals with Duchenne Muscular Dystrophy (DMD) aimed at creating a database of functional motor abilities in this population to support validation efforts of the Duchenne Video Assessment (DVA).

Study Locations (1)

Maryland

  • Emmes - Rockville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-09-01
Est. Completion 2026-01-11

Sponsor

The Emmes Company

11 total trials

What the Registry Record Tells You About NCT05712447

The ClinicalTrials.gov registry entry for NCT05712447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 409-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (63% lower). The listed sponsor is The Emmes Company, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.

NCT05712447 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05712447 about?

NCT05712447 is a clinical study titled "Duchenne Muscular Dystrophy Video Assessment Registry". ARISE is a prospective and longitudinal clinical study of individuals with Duchenne Muscular Dystrophy (DMD) aimed at creating a database of functional motor abilities in this population to support validation efforts of the Duchenne Video Assessment (DVA).

What is the current status of trial NCT05712447?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2022-09-01. Estimated completion is 2026-01-11.

What conditions does trial NCT05712447 study?

This clinical trial studies the following conditions: Duchenne Muscular Dystrophy.

Who is sponsoring clinical trial NCT05712447?

This trial is sponsored by The Emmes Company, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05712447 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Duchenne Muscular Dystrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.